- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07761208
Turkish Version of the Pictorial Pain Interference Questionnaire
8. august 2026 opdateret af: Yunus Emre Tutuneken, Istinye University
Assessment of the Functional Impact of Chronic Pain: Psychometric Properties of the Turkish Version of the Pictorial Pain Interference Questionnaire
This study aims to culturally adapt the Pictorial Pain Interference Questionnaire into Turkish and evaluate its psychometric properties in individuals with chronic pain.
The study will assess the validity and reliability of the Turkish version for evaluating the functional impact of chronic pain on daily life activities.
Reliability will be examined through internal consistency and test-retest reliability, while validity will be assessed by examining the relationships between the questionnaire and established pain-related assessment tools.
The study will determine whether the Turkish version provides a valid, reliable, and practical instrument for assessing functional interference associated with chronic pain in Turkish-speaking individuals.
Studieoversigt
Status
Ikke rekrutterer endnu
Betingelser
Intervention / Behandling
Undersøgelsestype
Observationel
Tilmelding (Anslået)
100
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Prøveudtagningsmetode
Ikke-sandsynlighedsprøve
Studiebefolkning
Adults aged 18 years and older with chronic pain lasting for at least 3 months
Beskrivelse
Inclusion Criteria:
- Having chronic pain lasting for at least 3 months.
- Willing to participate in the study and providing informed consent.
- Having sufficient cognitive ability to understand the questions.
Exclusion Criteria:
- Severe cognitive impairment (e.g., dementia) or conditions that interfere with communication.
- Inability to cooperate due to a psychiatric disorder.
- Neurological or serious systemic diseases that may affect the assessment.
- Incomplete or incorrectly completed questionnaires.
- Refusal to participate or withdrawal from the study.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Internal Consistency of the Turkish Pictorial Pain Interference Questionnaire
Tidsramme: At the first assessment (Baseline)
|
Internal consistency will be assessed using Cronbach's alpha coefficient.
|
At the first assessment (Baseline)
|
|
Test-Retest Reliability of the Turkish Pictorial Pain Interference Questionnaire
Tidsramme: Baseline and 7 days
|
Test-retest reliability will be assessed using the Intraclass Correlation Coefficient (ICC) based on assessments performed 7 days apart.
|
Baseline and 7 days
|
|
Construct Validity of the Turkish Pictorial Pain Interference Questionnaire
Tidsramme: Baseline
|
Construct validity will be evaluated by examining the correlations between the questionnaire scores and scores from the Brief Pain Inventory.
|
Baseline
|
|
Construct Validity of the Turkish Pictorial Pain Interference Questionnaire
Tidsramme: Baseline
|
Construct validity will be evaluated by examining the correlations between the questionnaire scores and scores from the Pain Disability Index.
|
Baseline
|
|
Construct Validity of the Turkish Pictorial Pain Interference Questionnaire
Tidsramme: Baseline
|
Construct validity will be evaluated by examining the correlations between the questionnaire scores and scores from the Oswestry Disability Index.
|
Baseline
|
|
Construct Validity of the Turkish Pictorial Pain Interference Questionnaire
Tidsramme: Baseline
|
Construct validity will be evaluated by examining the correlations between the questionnaire scores and scores from the Short-Form McGill Pain Questionnaire.
|
Baseline
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Discriminant Validity of the Turkish Pictorial Pain Interference Questionnaire
Tidsramme: Baseline
|
Discriminant validity will be assessed by examining correlations with concepts expected to have weak associations with pain, including positive affect.
|
Baseline
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Anslået)
20. august 2026
Primær færdiggørelse (Anslået)
15. februar 2027
Studieafslutning (Anslået)
22. februar 2027
Datoer for studieregistrering
Først indsendt
8. august 2026
Først indsendt, der opfyldte QC-kriterier
8. august 2026
Først opslået (Faktiske)
12. august 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
12. august 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
8. august 2026
Sidst verificeret
1. august 2026
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 101 (Hamilton Integrated Research Ethics Board)
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .